DeAngelo, D J <br/><br/>
Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia.  [electronic resource] 

 -  Leukemia  Mar 2015 
 - 526-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2014.229  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Asparaginase--administration & dosage<br/>Cytarabine--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Karyotyping<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Precision Medicine<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Prednisone--administration & dosage<br/>Remission Induction<br/>Survival Analysis<br/>Treatment Outcome<br/>Vincristine--administration & dosage